Glasgow lab will manage blood samples for the Guardant Health SHIELD lung cancer screening study in the EU. February 1, 2023 – Piscataway, NJ – Sampled1 today announced that the new genomics Sampled SMART Lab in Glasgow, UK, has initiated a project with Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, to manage […]
Press Releases
Sampled Leader Highlights Role of Biobanking in Addressing Historic Inequities in Healthcare
Diversity in Bio-sample Collection is Critical to the Development of Personalized Medicines November 15, 2022 – Piscataway, NJ – The Chief Scientific Officer at Sampled1 issued a call to action for greater diversity in clinical trial recruitment and the collection of biosamples in a letter in the current issue of Biopreservation and Biobanking. The letter […]
Sampled Launch New Informatics Platform, SampledSphere.
October 11, 2022 – Piscataway, NJ: Sampled1 launch new informatics platform, SampledSphere. SampledSphere is a new informatics platform built from the ground up to provide a 360-degree view of a biosample managed by a Sampled SMART Lab. SampledSphere, is a next generation informatics platform that allows researchers to leverage the data around their samples including […]
Sampled Appoints Sarah Hersey, VP, Head of Translational Sciences & Diagnostics at Bristol Myers Squibb, as its First Independent Director
PISCATAWAY, N.J. – June 15th, 2022: Infinity BiologiX LLC d/b/a Sampled SMART Labs, announced today the appointment of Sarah Hersey, a 25-year life sciences veteran, to its Board of Directors as its first Independent Director. Sarah brings a wealth of experience in precision medicine and biopharmaceutical research and development gained from leadership positions throughout the […]
Sampled Expand Global Footprint with New Lab in UK
NEW LAB OPENING BRINGS EXPANDED CAPABILITIES TO EUROPEAN CLIENTS 3000sqft Sampled SMART Lab expansion based in UK New capabilities for European clients focussed on biosample research and analysis Capabilities include genomics, epigenomics, PBMC isolation, bioprocessing, DNA/RNA extraction and sample storage PISCATAWAY, N.J. – June 29, 2022: Infinity BiologiX LLC d/b/a Sampled SMART Labs, open new […]
US launch of first polygenic test to predict risk of cognitive decline due to Alzheimer’s disease
Infinity BiologiX, Cytox, and Vanguard Pharma announce the US launch of the first, physician use only, polygenic test to predict the risk of cognitive decline due to Alzheimer’s disease.
